<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27579749</article-id>
      <article-id pub-id-type="pmc">4999112</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20164764</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary cutaneous plasmablastic lymphoma revealing clinically
unsuspected HIV infection<xref ref-type="fn" rid="fn1">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Silvio Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abbade</surname>
            <given-names>Luciana P. Fernandes</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guiotoku</surname>
            <given-names>Marcelo Massaki</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marques</surname>
            <given-names>Mariangela Esther Alencar</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Universidade Estadual Paulista "J&#xFA;lio de Mesquita
Filho" (UNESP) - Botucatu (SP), Brazil.</aff>
      <aff id="aff2"><label>2</label>Clinica Particular - S&#xE3;o Paulo (SP), Brazil.</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Silvio Alencar Marques, Departamento de
Dermatologia e Radioterapia da Faculdade de Medicina de Botucatu - UNESP,
Distrito de Rubi&#xE3;o Junior S/N, 18618-970 - Botucatu - SP, Brazil. E-mail:
<email>smarques@fmb.unesp.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>4</issue>
      <fpage>507</fpage>
      <lpage>509</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Plasmablastic lymphoma is a rare subtype of diffuse large B-cell lymphoma more
frequently diagnosed in immunosuppressed patients, mainly HIV-infected. Primary
cutaneous plasmablastic lymphoma is extremely rare, and in this patient it was
the first clinical manifestation of unsuspected HIV-infection.</p>
      </abstract>
      <kwd-group>
        <kwd>HIV Infections</kwd>
        <kwd>Lymphoma, Skin Neoplasms</kwd>
        <kwd>AIDS-Related</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Plasmablastic lymphoma is a non-Hodgkin lymphoma regarded as a distinct subtype of
diffuse large B-cell lymphoma (DLBCL).<sup><xref rid="r1" ref-type="bibr">1</xref></sup> It is frequently associated with immunosuppression, mainly human
immunodeficiency virus (HIV-induced). Delecleuse HJ <italic>et al.</italic> (1997)
reported 16 clinical cases of aggressive lymphoma, 15 of which were on HIV-infected
individuals who displayed the buccal mucosa as the site of primary
involvement.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> As additional
characteristics, the tumors showed plasmacytoid differentiation and positivity to
Epstein-Barr virus (EBV) infection in 60% of the patients.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> From the first cases in 1997 until 2008, around 112
HIV-associated cases had been reported, most of which were in male patients (7:1),
average age 38 and &#x2264; 200 CD4 T-lymphocytes/mm<sup><xref rid="r3" ref-type="bibr">3</xref></sup>. In 65 of those patients (58%), buccal mucosa was
the primary site followed by the gastrointestinal tract in 15 patients
(13%).<sup><xref rid="r3" ref-type="bibr">3</xref></sup> In all cases, at
least one plasma-cell marker (CD38, CD138 or MUM1) was positive. Although they were
B-cell lymphomas, CD20 was positive in only 3% of those reported cases.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Primary cutaneous plasmablastic
lymphomas are extremely rare with only 12 cases reported by 2014.<sup><xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> We present a clinical case of highly aggressive primary
cutaneous plasmablastic lymphoma revealing clinically unsuspected HIV infection.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 60-year-old female patient was admitted for evaluation of a two-year tumoral skin
lesion on the leg. She reported occasional fever, weight loss (about 20kg in six
months) and eventual clinical worsening. Physical examination revealed a phagedenic
and terebrant ulcer with necrotic aspect in the center of the lesion. We observed
nodules and tumors in upper limits and an infiltrative and indurate aspect in distal
limits (<xref ref-type="fig" rid="f1">Figures 1</xref> and <xref ref-type="fig" rid="f2">2</xref>). Oral thrush was also observed. Based on clinical
observations, we suspected non-Hodgkin lymphoma or fibrosarcoma. Histopathology
examination revealed the same pattern in all sections: dense monomorphic atypical
lymphocytic infiltration of superficial and deep dermis. Lymphocytes showed
plasmacytoid differentiation with abundant eosinophilic cytoplasm, eccentric nucleus
and prominent nucleolus (<xref ref-type="fig" rid="f3">Figures 3</xref> and <xref ref-type="fig" rid="f4">4</xref>). Lesions demonstrated multiple mitosis.
Immunostaining was positive for CD38 and CD138 and negative for CD3, CD20 and CD45
(<xref ref-type="fig" rid="f5">Figure 5</xref>). KI-67 proliferative index was
highly positive (80%). Image analysis and bone marrow biopsy revealed no systemic
involvement caused by the lymphoma. In situ hybridization identified EBV genome
within tumor cells and EBV serology was positive for IgG and negative for IgM.
Serological investigation for HIV-infection was positive and presented CD4
T-lymphocytes 93 cells/mm3, CD8 T-lymphocytes = 1403/mm3 and viral load of 80.000
copies/ml. Human herpesvirus-8 (HHV-8) investigation by PCR was negative. Additional
clinical or laboratory analysis were unremarkable. The final diagnosis was primary
cutaneous plasmablastic lymphoma associated with HIV-infection. Differential
histopathological diagnoses considered in this case were plasma cell neoplasm with a
plasmablastic morphology, another HIV-related aggressive diffuse large B-cell
lymphoma and primary cutaneous B-cell lymphoma, leg-type.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Plasmablastic lymphoma: a phagedenic and terebrant ulce with nodules and
tumors on its upper limits</p>
          </caption>
          <graphic xlink:href="abd-91-04-0507-g01"/>
        </fig>
      </p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Plasmablastic lymphoma: distal limits showing infiltrative and indurate
aspect</p>
          </caption>
          <graphic xlink:href="abd-91-04-0507-g02"/>
        </fig>
      </p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Plasmablastic lymphoma: dense monomorphic atypical lymphocytic
infiltration of superficial and deep dermis. Epidermis is preserved. HE
100X</p>
          </caption>
          <graphic xlink:href="abd-91-04-0507-g03"/>
        </fig>
      </p>
      <p>
        <fig id="f4" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Plasmablastic lymphoma: cells with a plasmacytoid appearence with a
clock-face condensation of the chromatin. HE 1000X</p>
          </caption>
          <graphic xlink:href="abd-91-04-0507-g04"/>
        </fig>
      </p>
      <p>
        <fig id="f5" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Plasmablastic lymphoma: neoplastic cells staining for CD138. IMQ 400X</p>
          </caption>
          <graphic xlink:href="abd-91-04-0507-g05"/>
        </fig>
      </p>
      <p>CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) chemotherapy
regimen was associated with antiretroviral treatment (HAART). Nevertheless, the
patient could stand only one cycle of standard CHOP chemotherapy and died 21 days
after the diagnosis.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Non-Hodgkin lymphoma, Kaposi sarcoma and invasive carcinoma of the uterine cervix are
the only tumors included in the HIV surveillance data.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Non-Hodgkin lymphomas (NHL) are much more frequent
among HIV-infected individuals than the general population. 90% of those NHL are
B-cell lymphomas, most of which are extranodal such as the primary central nervous
system lymphoma, Burkitt's lymphoma and diffuse large B-cell lymphomas.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> Plasmablastic lymphoma is a subtype
of DLBCL with specific characteristics: a typical extranodal lymphoma associated
with immunosuppression, mostly HIV-induced and mostly seen in the buccal mucosa. It
occurs less often in transplanted patients and rarely in non-immunosuppressed
individuals. Histopathology usually shows a dense infiltrate of immunoblast-like or
plasmablast-like cells with strong positivity to CD38, CD138, MUM1 and negativity
for T-cell markers. In general, only 2%-3% of the cells are positive for CD20. KI-67
immunostaining reveals 50%-100% positivity.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> In situ hybridization identifies EBV genome within tumor
cells in up to 75% of the cases when using EBV-encoded small RNA (EBER) probes or
antibody staining for latent membrane protein.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> Its pathogenic role would be to provide protection against
apoptosis of lymphocyte B through amplification of MYC oncogene expression in a
similar mechanism observed in Burkitt's lymphoma.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> The detection of concomitant HHV-8 infection occurs in less
than 50% of the cases and its etiopathogenic role in developing the plasmablastic
lymphoma is not well defined.<sup><xref rid="r8" ref-type="bibr">8</xref></sup></p>
      <p>The clinical presentation of buccal plasmablastic lymphoma is of a rapidly growing
tumoral and painful mass, mostly located on gingiva, followed by lesions on palate
and the floor of the mouth, which may infiltrate the adjacent bone.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Although primary cutaneous plasmablastic lymphoma is extremely rare, it seems to
share a common pattern, namely the incidence of an ulcerative or infiltrative lesion
on the legs.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> Its diagnosis implies
the investigation of subjacent immunosuppression, particularly HIV-induced. However,
it can also be observed in patients in immunosenescence state when the term
plasmablastic lymphoma of the elderly (PBL-E) is used.<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>Treatment has not been standardized. Case-by-case decisions have been proposed with
the use of CHOP chemotherapy regimen, radiation therapy, surgical excision or
combination of these methods. The addition of HAART is the rule in case of
HIV-related plasmablastic lymphoma.<sup><xref rid="r8" ref-type="bibr">8</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at Departament of Dermatology and Radiotherapy - School of
Medicine -Universidade Estadual Paulista "J&#xFA;lio de Mesquita Filho"
(UNESP) - Botucatu (SP), Brazil.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="confproc">
          <person-group person-group-type="author">
            <name>
              <surname>Stein</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <source>Plasmablastic lymphoma</source>
          <person-group person-group-type="editor">
            <name>
              <surname>Swerdlow</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Campo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>SA</given-names>
            </name>
            <etal/>
          </person-group>
          <conf-name>World Health Organization classification of tumors of hematopoietic
and lymphoid tissues</conf-name>
          <edition>4th ed</edition>
          <publisher-name>IARC Press Lyon</publisher-name>
          <year>2008</year>
          <fpage>256</fpage>
          <lpage>257</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Delecluse</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Anagnostopoulos</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dallenbach</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hummel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marafioti</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Plasmablastic lymphomas of the oral cavity: A new entity
associated with the human immunodeficiency virus infection</article-title>
          <source>Blood</source>
          <year>1997</year>
          <volume>89</volume>
          <fpage>1413</fpage>
          <lpage>1420</lpage>
          <pub-id pub-id-type="pmid">9028965</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castillo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pantanowitz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dezube</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>HIV-associated plasmablastic lymphoma: Lessons learned from 112
published cases</article-title>
          <source>Am J Hematol</source>
          <year>2008</year>
          <volume>83</volume>
          <fpage>804</fpage>
          <lpage>809</lpage>
          <pub-id pub-id-type="pmid">18756521</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tiong</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Strauss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Chiruka</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous plasmablastic lymphoma in an immunocompetent patient
with long-term pyrimethamine Use for essential chrombocythemia: A Case
report and literature review</article-title>
          <source>Case Rep Hematol</source>
          <year>2013</year>
          <volume>2013</volume>
          <fpage>541783</fpage>
          <lpage>541783</lpage>
          <pub-id pub-id-type="pmid">23476834</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tavares</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Magalh&#xE3;es</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>de Moraes</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Pi&#xF1;eiro-Maceira</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ramos-e-Silva</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma: a rare and exuberant cutaneous emergence
in na immunocompetent patient</article-title>
          <source>Int J Dermatol</source>
          <year>2015</year>
          <volume>54</volume>
          <fpage>e175</fpage>
          <lpage>e178</lpage>
          <pub-id pub-id-type="pmid">25311439</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheung</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Pantanowitz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dezube</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>AIDS-related malignancies: emerging challenges in the era of
highly active antiretroviral therapy</article-title>
          <source>Oncologist</source>
          <year>2005</year>
          <volume>10</volume>
          <fpage>412</fpage>
          <lpage>426</lpage>
          <pub-id pub-id-type="pmid">15967835</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carolis</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Solari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Villafa&#xF1;e</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Schtirbu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lewi</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Non- Hodgkin's lymphoma with cutaneous involvement in AIDS
patients. Report of five cases and review of the literature</article-title>
          <source>Braz J Infect Dis</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>81</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">20428660</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castillo</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Reagan</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic Lymphoma: A Systematic review</article-title>
          <source>ScientificWorldJournal</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>687</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">21442146</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valera</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Balagu&#xE9;</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Colomo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mart&#xED;nez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Delabie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Taddesse-Heath</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>IG/MYC rearrangements are the main cytogenetic alteration in
plasmablastic lymphomas</article-title>
          <source>Am J Surg Pathol</source>
          <year>2010</year>
          <volume>34</volume>
          <fpage>1686</fpage>
          <lpage>1694</lpage>
          <pub-id pub-id-type="pmid">20962620</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarode</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Sarode</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Patil</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Plasmablastic lymphoma of the oral cavity: A
review</article-title>
          <source>Oral Oncol</source>
          <year>2010</year>
          <volume>46</volume>
          <fpage>146</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">20138565</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
